With only 41 out of top 100 pharmaceutical firms responding to its direction to register for online database, the National Pharmaceutical Pricing Authority (NPPA) has warned of action against the rest of them if they do not comply with its order immediately.
National drug pricing regulator NPPA had in September last year asked all pharma firms to register themselves with Integrated Pharmaceutical Database Management System (IPDMS).
“Many pharma companies have yet not registered with IPDMS despite extension of time limit by NPPA. It has been observed that out of top 100 pharma companies, 59 companies have not registered with the system,” NPPA said in a notice to pharma industry bodies on its website.
The list of 59 companies which have not registered include Zydus Cadila, Dr Reddy’s Labs, IPCA Labs and Biocon, among others.
Stating that it would be launching the system shortly, NPPA said, “You are therefore requested to impress among your member companies to register themselves with IPDMS immediately, failing which NPPA shall be constrained to take appropriate action.”
The regulator had last September asked all pharmaceutical firms to register themselves under the IPDMS for online filing of returns for monitoring, fixing and revision of drug prices.
It had said that availability of reliable database is a necessary pre-requisite for carrying out the functions of price fixation and price revision in respect of scheduled drugs and price fixation in respect of new drugs.
